Administrative Responsibilities

The Associate Dean for Outcomes Assessment and Accreditation provides strategic leadership in developing, implementing, and improving the College of Pharmacy's assessment plan and accreditation processes. This role ensures programmatic evaluation of the College's strategic goals and maintains compliance with accreditation standards. Key responsibilities include coordinating programmatic assessment of the College's missions, with emphasis on the PharmD curriculum and co-curriculum, and leading data collection, analysis, and reporting to drive continuous improvement in educational outcomes. The Associate Dean oversees curriculum mapping, monitors progress towards strategic initiatives, and coordinates evaluations for undergraduate, graduate and professional programs. Additionally, this position manages key educational technology systems supporting the PharmD program, provides faculty development related to assessment practices, and collaborates with College leadership to support assessment and accreditation efforts.

Education

Pharm.D.  Medical University of South Carolina, 2008

Critical Care Residency, Medical University of South Carolina
Pharmacy Practice Residency, Medical University of South Carolina

Background

Brie Dunn, Pharm.D., is the Associate Dean for Outcomes Assessment & Accreditation and a Clinical Associate Professor at the University of South Carolina College of Pharmacy. Dr. Dunn completed her Doctor of Pharmacy degree in addition to a Pharmacy Practice and Critical Care Residency at the Medical University of South Carolina in Charleston. She has received multiple recognitions for excellence in teaching, including the 2014 American College of Clinical Pharmacy New Educator of the Year, the 2015 University of South Carolina Clinical Practice Teaching Award and the 2016 inaugural University of Sout Carolina Garnet Apple Award for Teaching Innovation.

In addition to her administrative role, Dr. Dunn teaches a variety of cardiology and critical care topics at the college and serves as faculty advisor for the Phi Lambda Sigma Leadership Society Zeta chapter. She is active in local, state and national pharmacy organizations and is a past recipient of the South Carolina Society of Health-System Pharmacists George D. Schwerin Mentor Award.

Research Interests

• Educational technologies
• Programmatic assessment
• Scholarship of teaching and interprofessional education

Awards & Honors

• Professor of the Year, USC College of Pharmacy, 2024
• P2 Class Teacher of the Year, USC College of Pharmacy, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2022, 2024
• P3 Class Teacher of the Year, USC College of Pharmacy, 2017, 2022, 2023
• Outstanding Guest Lecturer Award, University of South Carolina School of Medicine Columbia, 2022
• Outstanding Chapter Advisor Award, Phi Lambda Sigma, 2020
• Leadership Fellows Program, American Association of Colleges of Pharmacy, 2019
• Garnet Apple Award for Teaching Innovation, University of South Carolina, 2016
• Professor of the Year, South Carolina College of Pharmacy, 2016, 2013
• George D. Schwerin Mentor Award, South Carolina Society of Health-System Pharmacists, 2016
• Clinical Practice Teaching Award, University of South Carolina, 2015
• New Educator Award, American Colleges of Clinical Pharmacy, 2014

Publications

Dunn BL, Page R. Chapter 13: Acute coronary syndrome. Applied Therapeutics: The Clinical Use of Drugs, 12th ed. Wolters Kluwer 2022.

Browne T, Blake EW, Baliko B, Christopher RL, Iachini AL, Dunn BL, Bethel SR, Ray D. Health equity in interprofessional education. Clin Teach 2021;000:1-3. doi: 10.1111/tct.13330

Iachini AL, Kim J, Browne T, Blake EW, Dunn B. A mixed-method longitudinal study of an interprofessional education course. J Interprof Care 2021;30:106. doi: 10.1080/13561820.2021.1884052

Iachini AL, DeHart DD, Browne T, Dunn B, Blake B, Blake C. Examining collaborative leadership through interprofessional education: findings of a mixed methods study. J Interprof Care 2019;33(2):235-242. doi: 10.1080/13561820.2018.1516635

Dunn BL, Page R. Chapter 13: Acute coronary syndrome. Applied Therapeutics: The Clinical Use of Drugs, 11th ed. Wolters Kluwer 2018.

Hammond DA, Oyler D, Branan TN, Barletta J, Bolesta S, Dunn BL, Haney JS, Juang P, Kane-Gill S, Kiser T, Shafeeq H, Skaar D, Smithburger pL, Swanson J, Taylor JL, Bailey BJ, Painter JT, Devlin J for the POLS Network. Perceived motivating factors and barriers for the completion of postgraduate training among American pharmacy students. Am J Pharm Educ 2017;81(5):1-13.

Love BL, Dunn BL, Darby AG, Mouratev GI. Dabigatran associated esophagitis. J S C Med Assoc 2016;112(3):226-227.

Rosemond TN, Blake C, Buff SM, Blake EW, Dunn BL, Browne T, Bell BA, Iachini AL. Sensitizing future health professionals to determinants of childhood obesity. Am J Prev Med2016;51(1):106-113.

Iachini AL, Dunn BL, Blake C, Blake EW. Evaluating the perceived impact of an interprofessional childhood obesity course on competencies for collaborative practice. J Interprof Care2016;30(3):394-396.

Shrader S, Dunn BL, Blake E, Phillips C. Incorporating standardized colleagues in a clinical assessment course and evaluating the impact on interprofessional communication. Am J Pharm Educ 2015;79(4):1-8.

Sutton SS, Quidley AM, Bland CM, Dunn BL. Sepsis and septic shock. In Sutton SS. Naplex Review Guide, 2^nded. McGraw-Hill 2015.

Bland C, Sutton SS, Dunn BL. What are the latest recommendations for managing severe sepsis and septic shock? JAAPA2014;27:15-19.

Bland C, Bookstaver B, Lu Z, Dunn BL, Rumley K. Musculoskeletal safety outcomes of patients receiving Daptomycin with HMG-CoA reductase inhibitors. Antimicrob Agents Chemother2014;58:5726-5731.

Bennett CL, Jacob S, Dunn BL, et al. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol2013;161(6):896-8.

Jacob S, Dunn BL, Qureshi ZP, et al. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: A twenty-year systematic review of a serious adverse hematologic toxicity associated with essential cerebro-cardiovascular therapy.  Semin Thromb Hemost 2012;38(8):845-53.

Dunn BL, Teusink AC, Taber DJ, Hemstreet BA, Uber L, Weimert NA.  Management of hypertension in renal transplant patients: A comprehensive review of non-pharmacologic and pharmacologic treatment strategies.  Ann Pharmacother 2010;44(7-8):1259-70.

Dunn BL, Garner S, Spencer AP, Ragucci KR. Survey of colleges of pharmacy to assess preparation and promotion of residency training.  Am J Pharm Educ2010;74(3):1-5.

Dunn BL, Uber WE, Ikonomidis JS.  Topical thrombin preparations and their use in cardiac surgery. Open Access Surgery2009;2:15-34.